Early Risk Stratification of Chronic Kidney Disease and Dialysis Requirement Using Clinical Data
DOI:
https://doi.org/10.65327/kidneys.v15i2.667Keywords:
CKD, Machine Learning, Risk Stratification, Dialysis Prediction, Clinical DataAbstract
Chronic Kidney Disease (CKD) is a long-term condition which is usually not diagnosed until there is significant renal damage, which can lead to dialysis and other serious complications. Thus, there is a need for early identification of high risk patients for better clinical outcome and disease burden reduction. This study introduces a machine learning-based approach for early risk-stratification of CKD and predicting the dialysis requirement from routine clinical data. The framework consists of two parts: demographic data, laboratory biomarkers and comorbidity data, followed by data preprocessing, exploratory analysis, development of predictive models and comparison of their performance. Several supervised machine learning models were developed and evaluated with the common performance metrics such as accuracy, precision, recall, F1-score and ROC-AUC. The most reliable predictive model was identified to differentiate the cases of CKD and to estimate dialysis requirement, when compared with the other models. The study results showed that machine learning approaches could be beneficial for early clinical decision making, as they can provide timely assessment of risk, better patient management and enable proactive intervention in patients at risk of CKD progression.
Downloads
References
Alobaidi, S. (2025). Emerging biomarkers and advanced diagnostics in chronic kidney disease: early detection through multi-omics and AI. Diagnostics, 15(10), 1225.
Bai, Q., Su, C., Tang, W., & Li, Y. (2022). Machine learning to predict end stage kidney disease in chronic kidney disease. Scientific reports, 12(1), 8377.
Brookes, E. M., & Power, D. A. (2022). Elevated serum urea-to-creatinine ratio is associated with adverse inpatient clinical outcomes in non-end stage chronic kidney disease. Scientific reports, 12(1), 20827.
Delrue, C., De Bruyne, S., & Speeckaert, M. M. (2024). Application of machine learning in chronic kidney disease: current status and future prospects. Biomedicines, 12(3), 568.
Dutta, S., Sikder, R., Islam, M. R., Al Mukaddim, A., Hider, M. A., & Nasiruddin, M. (2024). Comparing the effectiveness of machine learning algorithms in early chronic kidney disease detection. Journal of Computer Science and Technology Studies, 6(4), 77-91.
Farrell, D. R., & Vassalotti, J. A. (2024). Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?. BMC nephrology, 25(1), 34.
Franceschini, N., Feldman, D. L., Berg, J. S., Besse, W., Chang, A. R., Dahl, N. K., ... & Wong, C. S. (2024). Advancing genetic testing in kidney diseases: report from a National Kidney Foundation Working Group. American journal of kidney diseases, 84(6), 751-766.
Gao, Y. M., Chen, W. J., Deng, Z. L., Shang, Z., & Wang, Y. (2023). Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease. Frontiers in Endocrinology, 14, 1150980.
Gogoi, P., & Valan, J. A. (2025). Machine learning approaches for predicting and diagnosing chronic kidney disease: current trends, challenges, solutions, and future directions. International Urology and Nephrology, 57(4), 1245-1268.
Goldstein, S. L., Krallman, K. A., Roy, J. P., Collins, M., Chima, R. S., Basu, R. K., ... & Fei, L. (2023). Real-time acute kidney injury risk stratification–biomarker directed fluid management improves outcomes in critically ill children and young adults. Kidney International Reports, 8(12), 2690-2700.
Islam, M. A., Majumder, M. Z. H., & Hussein, M. A. (2023). Chronic kidney disease prediction based on machine learning algorithms. Journal of pathology informatics, 14, 100189.
Kumar, M., Dev, S., Khalid, M. U., Siddenthi, S. M., Noman, M., John, C., ... & AKUBUIRO, C. (2023). The bidirectional link between diabetes and kidney disease: mechanisms and management. Cureus, 15(9).
Lai, W., Xie, Y., Zhao, X., Xu, X., Yu, S., Lu, H., ... & Liu, Y. (2023). Elevated systemic immune inflammation level increases the risk of total and cause-specific mortality among patients with chronic kidney disease: a large multi-center longitudinal study. Inflammation Research, 72(1), 149-158.
Lees, J. S., Rutherford, E., Stevens, K. I., Chen, D. C., Scherzer, R., Estrella, M. M., ... & Shlipak, M. G. (2022). Assessment of cystatin C level for risk stratification in adults with chronic kidney disease. JAMA Network Open, 5(10), e2238300.
Major, R. W., Cockwell, P., Nitsch, D., & Tangri, N. (2022). The next step in chronic kidney disease staging: individualized risk prediction. Kidney international, 102(3), 456-459.
Matsushita, K., Ballew, S. H., Wang, A. Y. M., Kalyesubula, R., Schaeffner, E., & Agarwal, R. (2022). Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nature Reviews Nephrology, 18(11), 696-707.
Miah, A. (2025). Kidney Disease Risk Dataset: Chronic Kidney Disease (CKD) and Dialysis Risk Prediction. Kaggle. https://www.kaggle.com/datasets/miadul/kidney-disease-risk-dataset
Moreno-Sánchez, P. A. (2023). Data-driven early diagnosis of chronic kidney disease: development and evaluation of an explainable AI model. IEEE Access, 11, 38359-38369.
Neyra, J. A., Ortiz-Soriano, V., Liu, L. J., Smith, T. D., Li, X., Xie, D., ... & Chen, J. (2023). Prediction of mortality and major adverse kidney events in critically ill patients with acute kidney injury. American Journal of Kidney Diseases, 81(1), 36-47.
RAHMAN, M. H., Rahaman, M., Arafat, Y., Rahat, S. R. U. I., Hasan, R., RIMON, S. T. H., & Dipa, S. A. (2025). Artificial intelligence for chronic kidney disease risk stratification in the USA: Ensemble vs. deep learning methods. British journal of nursing studies, 5(2), 20-32.
Shoji, S., Kuno, T., Kohsaka, S., Amiya, E., Asleh, R., Alvarez, P., ... & Briasoulis, A. (2022). Incidence and long-term outcome of heart transplantation patients who develop postoperative renal failure requiring dialysis. The Journal of Heart and Lung Transplantation, 41(3), 356-364.
Silveira, A. C. D., Sobrinho, Á., Silva, L. D. D., Costa, E. D. B., Pinheiro, M. E., & Perkusich, A. (2022). Exploring early prediction of chronic kidney disease using machine learning algorithms for small and imbalanced datasets. Applied Sciences, 12(7), 3673.
Stewart, S., Kalra, P. A., Blakeman, T., Kontopantelis, E., Cranmer-Gordon, H., & Sinha, S. (2024). Chronic kidney disease: detect, diagnose, disclose—a UK primary care perspective of barriers and enablers to effective kidney care. BMC medicine, 22(1), 331.
Venkatesan, V. K., Ramakrishna, M. T., Izonin, I., Tkachenko, R., & Havryliuk, M. (2023). Efficient data preprocessing with ensemble machine learning technique for the early detection of chronic kidney disease. Applied Sciences, 13(5), 2885.
Wilkinson, T. J., Miksza, J., Zaccardi, F., Lawson, C., Nixon, A. C., Young, H. M., ... & Smith, A. C. (2022). Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease. Journal of cachexia, sarcopenia and muscle, 13(5), 2426-2435.
Zhu, Y., Bi, D., Saunders, M., & Ji, Y. (2023). Prediction of chronic kidney disease progression using recurrent neural network and electronic health records. Scientific reports, 13(1), 22091.

ISSN 2307-1257
ISSN 2307-1265














